← back to search

Robert Eil

University of Portland · US
Area of research
Immunology · Oncology
Research interest
Research interests include CAR-T cell therapy research, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, and Immunotherapy and Immune Responses.
h-index
20
citations
5,085
works
110
NIH funding
primary concept
Medicine
email

Recent publications

T cell stemness and dysfunction in tumors are triggered by a common mechanism
Science 2019cited by 525position: middledoi
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy
Journal of Clinical Investigation 2019cited by 156position: middledoi
Identification of essential genes for cancer immunotherapy
Nature 2017cited by 890position: middledoi
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy
JCI Insight 2017cited by 218position: middledoi
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche
Cell 2016cited by 240position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nicholas P. Restifo · Business Roundtable5 papers (2016–2019)Christopher A. Klebanoff · Memorial Sloan Kettering Cancer Center4 papers (2016–2019)Madhusudhanan Sukumar · Johnson & Johnson (United States)4 papers (2016–2019)Tori N. Yamamoto · University of California, San Francisco4 papers (2017–2019)Suman K. Vodnala · Lyell Immunopharma (United States)4 papers (2017–2019)Rigel J. Kishton · National Cancer Institute3 papers (2017–2019)Zhiya Yu · National Cancer Institute3 papers (2016–2019)Luca Gattinoni · University of Regensburg3 papers (2016–2019)Arash Eidizadeh · National Cancer Institute2 papers (2017–2019)Michael J. Kruhlak · National Heart Lung and Blood Institute2 papers (2017–2019)Douglas C. Palmer · AstraZeneca (Japan)2 papers (2016–2019)Shashank J. Patel · Indian Agricultural Research Institute2 papers (2017–2019)Devikala Gurusamy · National Heart Lung and Blood Institute2 papers (2017–2019)David Clever · The Ohio State University2 papers (2016–2017)Rahul Roychoudhuri · Center for Cancer Research2 papers (2016–2019)Ping‐Hsien Lee · AstraZeneca (United States)2 papers (2019–2019)Seth M. Steinberg · Center for Cancer Research1 papers (2017–2017)Jing Huang · Tianjin Normal University1 papers (2019–2019)Heather D. Hickman · National Institute of Allergy and Infectious Diseases1 papers (2016–2016)Jessica Fioravanti · Center for Cancer Research1 papers (2019–2019)